These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16297447)

  • 1. Multiple interaction sites of galnon trigger its biological effects.
    Florén A; Sollenberg U; Lundström L; Zorko M; Stojan J; Budihna M; Wheatley M; Martin NP; Kilk K; Mazarati A; Bartfai T; Lindgren M; Langel U
    Neuropeptides; 2005 Dec; 39(6):547-58. PubMed ID: 16297447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes.
    Wang S; Hashemi T; Fried S; Clemmons AL; Hawes BE
    Biochemistry; 1998 May; 37(19):6711-7. PubMed ID: 9578554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galnon--a low-molecular weight ligand of the galanin receptors.
    Sollenberg U; Bartfai T; Langel U
    Neuropeptides; 2005 Jun; 39(3):161-3. PubMed ID: 15944006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.
    Rajarao SJ; Platt B; Sukoff SJ; Lin Q; Bender CN; Nieuwenhuijsen BW; Ring RH; Schechter LE; Rosenzweig-Lipson S; Beyer CE
    Neuropeptides; 2007 Oct; 41(5):307-20. PubMed ID: 17637475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of feeding by galnon.
    Abramov U; Florén A; Echevarria DJ; Brewer A; Manuzon H; Robinson JK; Bartfai T; Vasar E; Langel U
    Neuropeptides; 2004 Feb; 38(1):55-61. PubMed ID: 15003717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of third intracellular loop of galanin receptor type 1 in signal transduction.
    Rezaei K; Saar K; Soomets U; Valkna A; Näsman J; Zorko M; Akerman K; Schroeder T; Bartfai T; Langel U
    Neuropeptides; 2000 Feb; 34(1):25-31. PubMed ID: 10688965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity.
    Lu X; Mazarati A; Sanna P; Shinmei S; Bartfai T
    Neuropeptides; 2005 Jun; 39(3):147-52. PubMed ID: 15944003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for hydrophobic interaction between galanin and the GalR1 galanin receptor and GalR1-mediated ligand internalization: fluorescent probing with a fluorescein-galanin.
    Wang S; Clemmons A; Strader C; Bayne M
    Biochemistry; 1998 Jun; 37(26):9528-35. PubMed ID: 9649336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G protein-coupled galanin receptor distribution in the rat central nervous system.
    Barreda-Gómez G; Giralt MT; Rodríguez-Puertas R
    Neuropeptides; 2005 Jun; 39(3):153-6. PubMed ID: 15944004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of central galanin administration on muscarinic cholinergic and galanin receptor G protein coupling.
    Barreda-Gómez G; Giralt MT; Rodríguez-Puertas R
    Neuropeptides; 2005 Jun; 39(3):157-60. PubMed ID: 15944005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of the ligand binding site of the human galanin receptor type 2, identifying subtype selective interactions.
    Lundström L; Sollenberg UE; Bartfai T; Langel U
    J Neurochem; 2007 Dec; 103(5):1774-84. PubMed ID: 17953676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galanin (2-11) binds to GalR3 in transfected cell lines: limitations for pharmacological definition of receptor subtypes.
    Lu X; Lundström L; Bartfai T
    Neuropeptides; 2005 Jun; 39(3):165-7. PubMed ID: 15944007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The galanin signaling cascade is a candidate pathway regulating oncogenesis in human squamous cell carcinoma.
    Sugimoto T; Seki N; Shimizu S; Kikkawa N; Tsukada J; Shimada H; Sasaki K; Hanazawa T; Okamoto Y; Hata A
    Genes Chromosomes Cancer; 2009 Feb; 48(2):132-42. PubMed ID: 18973137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroanatomical characterization of the G protein-coupled receptor activity evoked by galanin-related ligands.
    Barreda-Gómez G; Manuel I; Rodríguez-Puertas R
    J Chem Neuroanat; 2023 Mar; 128():102226. PubMed ID: 36566994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand binding properties of human galanin receptors.
    Jurkowski W; Yazdi S; Elofsson A
    Mol Membr Biol; 2013 Mar; 30(2):206-16. PubMed ID: 23237663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of limbic status epilepticus by hippocampal galanin type 1 and type 2 receptors.
    Mazarati A; Lu X
    Neuropeptides; 2005 Jun; 39(3):277-80. PubMed ID: 15944022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu-delta opioid receptor functional interaction: Insight using receptor-G protein fusions.
    Snook LA; Milligan G; Kieffer BL; Massotte D
    J Pharmacol Exp Ther; 2006 Aug; 318(2):683-90. PubMed ID: 16690720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galanin receptor ligands.
    Lu X; Lundström L; Langel U; Bartfai T
    Neuropeptides; 2005 Jun; 39(3):143-6. PubMed ID: 15944002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic galnon, a low-molecular weight galanin receptor agonist, reduces heat hyperalgesia in rats with nerve injury.
    Wu WP; Hao JX; Lundström L; Wiesenfeld-Hallin Z; Langel U; Bartfai T; Xu XJ
    Eur J Pharmacol; 2003 Dec; 482(1-3):133-7. PubMed ID: 14660014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y; Toyoshima R
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.